- Static Telepathology
- Dynamic Telepathology
- Hybrid Telepathology
Telepathology Market size was valued at USD 645.37 million in 2022 and is expected to reach a value of USD 1,788 million by 2029, at a CAGR of 12.15% from 2023 and 2029. Telepathology referred as practising pathology from a distance and telecommunication technology is used for facilitating the transmission of pathology image rich data between two distant locations for diagnosis, research and education. Pathology plays a very important role in identifying the characteristics and causes of the diseases in medical field. Electronic medical records also increase the administrative efficiency and reduces the medical cost. There are three modes of telepathology are static (or store-and-forward), dynamic (or real-time) and hybrid (or virtual. Static telepathology refers to the process of pre-selection and digitalisation of representative image by sender pathologist and sending it to the remote pathologist via e-mail or internet. Dynamic telepathology is most appropriate system for frozen-selection telepathology and for understaffed area. This involves transmission of microscopic slide images to recipient in real time via live communication. Whereas, hybrid pathology is combining both static and dynamic telepathology modes, a series of images that automatically stitched together in a software, compressed to a single file form and transmitted on the dynamic telepathology session start. Telepathology Market is technology-driven segment of medical field. It is an innovative digital imaging and telecommunication technology that is changing the healthcare delivery systems globally. The regional players are involving in acquisition of the pathology providers that present locally and strengthening their position in market.
Telepathology Market Key Developments:
- For instance, in November 2016, Visiopharm A/S acquired LRI Imaging AB, a leading diagnostic digital pathology provider in Sweden to become leader in diagnostic digital pathology.
- Similarly, in June 2016, Philips acquired an Irish digital pathology firm, PathXL and its digital pathology imaging technology. By this acquisition, Philips seeks to accelerate drive to support global medical institutions and their transition to digitalize workflows.
Telepathology Market Summary
Study Period
2023-29
Base Year
2022
CAGR
12.15%
Largest Market
North America
Fastest Growing Market
Europe
Telepathology Market Dynamics
The telepathology market is driven by the technological advancements, digitalization of pathology. In addition, extended reach, cost-effectiveness of the services and quick diagnosis are expected to bolster the global telepathology market over the forecast period. Furthermore, ease of operation, increase in government funding for hospitals and growing demand for telemedicine are also expected to further boost the market growth during the forecast period. However, factors such as the high cost of devices, lack of skilled professionals, and lack of infrastructure in underdeveloped and developing countries expected to hamper the market growth over the forecast period. Moreover, monitoring of telepathology requires high amount of investment and errors in interpreting the digital data may act as restraints for the market growth.
North-America Got Significant Share
Telepathology Market Regional Analysis
Geographically, the market has been segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America market expected to grow at significant rates owing to the favourable healthcare policies that use digital pathology systems, well-established healthcare infrastructure and growing ageing population who are more susceptible to the physical problems that require imaging technologies for diagnosis. Europe telepathology market is expected to grow at notable rates owing to prevalence of the diseases such as cancer that require the pathological diagnosis, growing awareness and well-developed healthcare infrastructure. Asia Pacific region is expected to be a fastest growing market for telepathology owing to the developing healthcare infrastructure and digitalization of the medical services in order to deliver the cost-effective services. However, in developing countries such as India and China lack of skilled professionals and training for optimum utilisation of telepathology may hinder the market growth.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The telepathology market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Telepathology Market Segmentation
By Services
By Application
- Diagnosis
- Education
- Teleconsultation
- Research
By End User
- Pharmaceutical & Biotechnology Firms
- Hospitals
- Academic Institutions
- Others
By Geography
- Latin America
- Europe
- Asia Pacific
- Middle East
- North America
Frequently Asked Questions
The key segments covered in the telepathology market are: by services, application, and end-users
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Global Telepathology Market Introduction |
| 2.1.Global Telepathology Market - Taxonomy |
| 2.2.Global Telepathology Market - Definitions |
| 2.2.1.Services |
| 2.2.2.Application |
| 2.2.3. End-user |
| 2.2.4.Region |
| 3.Global Telepathology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Telepathology Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Telepathology Market By Services , 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Static Telepathology |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Dynamic Telepathology |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Hybrid Telepathology |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Telepathology Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Diagnosis |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Education |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Teleconsultation |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Research |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Telepathology Market By End-user, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Pharmaceutical & Biotechnology Firms |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Hospitals, |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Academic Institutions |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Telepathology Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Telepathology Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Services Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Static Telepathology |
| 9.1.2.Dynamic Telepathology |
| 9.1.3.Hybrid Telepathology |
| 9.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Diagnosis |
| 9.2.2.Education |
| 9.2.3.Teleconsultation |
| 9.2.4.Research |
| 9.3. End-user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Pharmaceutical & Biotechnology Firms |
| 9.3.2.Hospitals, |
| 9.3.3.Academic Institutions |
| 9.3.4.Others |
| 9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Telepathology Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Services Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Static Telepathology |
| 10.1.2.Dynamic Telepathology |
| 10.1.3.Hybrid Telepathology |
| 10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Diagnosis |
| 10.2.2.Education |
| 10.2.3.Teleconsultation |
| 10.2.4.Research |
| 10.3. End-user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pharmaceutical & Biotechnology Firms |
| 10.3.2.Hospitals, |
| 10.3.3.Academic Institutions |
| 10.3.4.Others |
| 10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11.Asia Pacific (APAC) Telepathology Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Services Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Static Telepathology |
| 11.1.2.Dynamic Telepathology |
| 11.1.3.Hybrid Telepathology |
| 11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Diagnosis |
| 11.2.2.Education |
| 11.2.3.Teleconsultation |
| 11.2.4.Research |
| 11.3. End-user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pharmaceutical & Biotechnology Firms |
| 11.3.2.Hospitals, |
| 11.3.3.Academic Institutions |
| 11.3.4.Others |
| 11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Telepathology Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Services Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Static Telepathology |
| 12.1.2.Dynamic Telepathology |
| 12.1.3.Hybrid Telepathology |
| 12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Diagnosis |
| 12.2.2.Education |
| 12.2.3.Teleconsultation |
| 12.2.4.Research |
| 12.3. End-user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pharmaceutical & Biotechnology Firms |
| 12.3.2.Hospitals, |
| 12.3.3.Academic Institutions |
| 12.3.4.Others |
| 12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Telepathology Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Services Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Static Telepathology |
| 13.1.2.Dynamic Telepathology |
| 13.1.3.Hybrid Telepathology |
| 13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Diagnosis |
| 13.2.2.Education |
| 13.2.3.Teleconsultation |
| 13.2.4.Research |
| 13.3. End-user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pharmaceutical & Biotechnology Firms |
| 13.3.2.Hospitals, |
| 13.3.3.Academic Institutions |
| 13.3.4.Others |
| 13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Southeastern Pathology Associates (U.S.) |
| 14.2.2.Visiopharm A/S (Denmark) |
| 14.2.3.Laboratory Corporation of America Holdings (LabCorp) (U.S.) |
| 14.2.4.University Health Network (Canada) |
| 14.2.5.Canada Health Infoway |
| 14.2.7.Telemedicine Clinic (TMC) (Spain) |
| 14.2.8.microDimensions (Germany) |
| 14.2.9.AMD Global Telemedicine, Inc. (U.S.) |
| 14.2.10.Polycom, Inc. (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Southeastern Pathology Associates (U.S.)
- Visiopharm A/S (Denmark)
- Laboratory Corporation of America Holdings (LabCorp) (U.S.)
- University Health Network (Canada)
- Canada Health Infoway
- Telemedicine Clinic (TMC) (Spain)
- microDimensions (Germany)
- AMD Global Telemedicine, Inc. (U.S.)
- Polycom, Inc. (U.S.)